Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05483465

The Effect of NAD Supplementation on Brain Vascular Health in Aging

Effects of NAD Restoration on Neurovascular Coupling in Community Dwelling Older Adults

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
214 (estimated)
Sponsor
University of Oklahoma · Academic / Other
Sex
All
Age
60 Years – 85 Years
Healthy volunteers
Accepted

Summary

Daily consumption of one of the forms of Vitamin B3, the Nicotinamide Riboside (NR), energizes the body and combats cellular aging. This study is designed to test whether NR can also improve brain health and memory.

Detailed description

This study is designed to test the hypothesis that restoration of Nicotinamide Adenine Dinucleotide (NAD) levels with Nicotinamide Riboside (NR) in older adults will improve neurovascular coupling (NVC) responses and micro- and macrovascular endothelial function. This hypothesis will be tested by assessing the effects of treatment with oral NR (1g/day per os for 8 weeks) or placebo (8 weeks) in community dwelling older adults (60-85 years of age).

Conditions

Interventions

TypeNameDescription
DRUGNicotinamide ribosideOral NR, 1g/day per os for 8 weeks
DRUGPlaceboVisually identical pill to NR, daily per os for 8 weeks

Timeline

Start date
2023-05-03
Primary completion
2027-06-01
Completion
2027-12-01
First posted
2022-08-02
Last updated
2026-04-01

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05483465. Inclusion in this directory is not an endorsement.